Literature DB >> 18421022

Peripubertal hyperinsulinemia upregulates phosphatidylinositol 3-kinase/akt pathway in rat ovaries.

Shilla Chakrabarty1, Manubai Nagamani.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) usually develops during peripuberty and is often associated with hyperinsulinemia. Paradoxically, hyperinsulinemic patients with PCOS develop peripheral insulin resistance but retain ovarian insulin sensitivity. We investigated the effect of peripubertal hyperinsulinemia on insulin signaling pathways in rat ovaries.
METHODS: Hyperinsulinemia was induced in peripubertal female rats by infusing insulin (0.14 IU/day) for 4 weeks. Control animals received normal saline. At autopsy, trunk blood was collected for insulin assay; ovaries were collected for examining the effect of hyperinsulinemia on phosphatidylinositol 3-kinase/Akt (PI3-K/Akt) and mitogen-activated protein kinase (MAPK/ERK1/2) pathways.
RESULTS: Compared with control, ovarian protein levels of total Akt, phospho-Akt, and phospho-glycogen synthase kinase-3beta were upregulated and phospho-phosphatase and tensin homolog was downregulated in hyperinsulinemic animals. The MAPK/ERK1/2 pathway was unaffected.
CONCLUSIONS: Peripubertal hyperinsulinemia upregulates the PI3-K/Akt pathway in rat ovaries. Ovarian insulin sensitivity in hyperinsulinemic patients with PCOS is potentially retained by this mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421022     DOI: 10.1177/1933719108316389

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  2 in total

1.  Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.

Authors:  Aileen F Keating; Shannon M Fernandez; Connie J Mark-Kappeler; Nivedita Sen; I Glenn Sipes; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2010-11-10       Impact factor: 4.285

2.  Reproductive tissues maintain insulin sensitivity in diet-induced obesity.

Authors:  Sheng Wu; Sara Divall; Fredric Wondisford; Andrew Wolfe
Journal:  Diabetes       Date:  2011-11-10       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.